SCHEMBL14848990

SCHEMBL14848990

Cc1cc(CCc2ccccc2)ccc1Br

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
MAOA P21397 4/20 0.44
MAOB P27338 4/20 0.44
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.40
IGF1R P08069 1/20 0.40
ALOX15 P16050 1/20 0.40
HDAC1 Q13547 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355390 0.81 MEN1 (0.43) MEN1POLBKMT2AALDH1A1TDP1
SCHEMBL2551561 0.81 MAOA (0.48) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL20048186 0.79 SKP2 (0.50) POLBKMT2AALDH1A1RAB9ACYP1A2
SCHEMBL18353303 0.79 SKP2 (0.50) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL27619133 0.79 SKP2 (0.41) MEN1POLBKMT2AALDH1A1TDP1
SCHEMBL31753689 0.78 ALDH1A1 (0.47) MEN1POLBKMT2AALDH1A1TDP1
SCHEMBL5524133 0.78 TAAR1 (0.50) ALDH1A1TDP1CYP1A2CYP2D6ALOX15
SCHEMBL11279849 0.78 ALDH1A1 (0.47) MEN1POLBKMT2AALDH1A1TDP1
SCHEMBL3192065 0.76 SKP2 (0.47) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL7638694 0.76 TAAR1 (0.48) MEN1KMT2AALDH1A1TDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9346770-B2 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2016-05-24 US disclosed
US-20130089613-A1 Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2013-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130089613-A1 Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses PPARA, PPARG, PPARD MEN1 4866/4885POLB 960/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.